Abstract:Wilson disease (WD), is a rare autosomal recessive inherited disease involving copper metabolism disturbance due to the mutations of ATP7B gene that encodes the P‐type ATPase. Early diagnosis and intervention of WD are critical to limit disease progression, and the disease is lethal if the patients is not treated early. The detection of ATP7B gene mutation may be powerful tools for WD accurately diagnosis, especially for patients who have mild to moderate disease. Therefore, we recruited 18 WD Chinese patients and their 43 first‐degree relatives from 16 families and 2 independent individuals for DNA sequencing to systematically analyze the genotypes of Chinese WD patients. We also conducted a series of experiments to elucidation of possible functional consequences of these ATP7B mutations. A total of 33 ATP7B gene variants were identified, including three variants with uncertain significance (VUS) [two splice mutations (c.51+2T>G, c.1543+40G>A) and one frameshift mutation (c.3532_3535del)]. The CCK‐8 and apoptosis assays demonstrated that the VUS of ATP7B could significantly affect the transportation of copper. Our study enriches the mutation spectrum of the ATP7B gene worldwide and provides valuable reference data for studying the mutation type and genetic mode of ATP7B in the Chinese population.ObjectivesWilson disease (WD) is a rare autosomal recessive genetic disorder associated with various mutations in the ATP7B gene and leads to significant disability or death if untreated. Early diagnosis and proper therapy usually predict a good prognosis, especially in pre‐symptomatic WD. Genetic testing provides an accurate and effective diagnostic method for the early diagnosis of WD.MethodsWe recruited 18 clinically diagnosed WD patients from 16 unrelated families and two independent individuals. The next‐generation sequencing of the ATP7B gene was performed. The 293T cell lines were divided into wild‐type (WT) ATP7B and mutated ATP7B groups. Cell proliferation was determined by Cell Counting Kit‐8 (CCK‐8) assay and apoptosis was detected by Annexin V/propidium iodide (PI) assays.ResultsPedigree analysis showed that compound heterozygous variants (17/18, 94.44%) were present in the majority of WD patients. A total of 33 ATP7B gene variants were identified, including three variants with uncertain significance (VUS) [two splice mutations (c.51+2T>G, c.1543+40G>A) and one frameshift mutation (c.3532_3535del)]. The CCK‐8 and apoptosis assays demonstrated that the VUS of ATP7B could significantly affect the transportation of copper.ConclusionsThe study revealed genetic defects of 16 Chinese families and two independent individuals with WD, which enriched the mutation spectrum of the ATP7B gene worldwide and provided valuable information for studying the mutation types of ATP7B in the Chinese populations. Genetic testing in WD patients is necessary to shorten the time to initiate therapy, reduce damage to the liver and improve the prognosis.

Generation of ZJUi003-A, an Induced Pluripotent Stem Cell Line from a Wilson's Disease Patient Carrying a C.180_181del Mutation in ATP7B Gene.

Generation of an Induced Pluripotent Stem Cell (ipsc) Line (Thsjtui001-A) from a Wilson's Disease Patient Harboring a Homozygous Arg778Leu Mutation in ATP7B Gene

Generation of an Induced Pluripotent Stem Cell Line (Zjulli003-A) from a Hypertrophic Cardiomyopathy Patient Carrying MYH7/c.4384G > A Mutation

Generation of Induced Pluripotent Stem Cell Line (Zzui007-A) from a 52-Year-old Patient with a Novel CHCHD2 Gene Mutation in Parkinson's Disease.

Establishment of an Induced Pluripotent Stem Cell Line (Zjulli004-A) from a Hypertrophic Cardiomyopathy Patient Carrying MYBPC3/c.3764C>A Mutation

Generation of Five Induced Pluripotent Stem Cell Lines with DMD/c.497G > T Mutation from Renal Epithelial Cells of a Duchenne Muscular Dystrophy Patient and a Recessive Carrier Parent

Generation of Induced Pluripotent Stem Cell Line (Zzui0012-A) from a Patient with Fahr's Disease Caused by a Novel Mutation in SLC20A2 Gene.

Generation of a Human Charcot-Marie-Tooth Disease Type 1B (CMT1B) Ipsc Line, ZJUCHi001-A, with a Mutation of C.292c>t in MPZ.

Hemolytic Anemia As First Presentation of Wilson's Disease with Uncommon ATP7B Mutation.

Generation of Induced Pluripotent Stem Cell Line, ZJUCHi002-A, from Charcot-Marie-Tooth Disease Type 2A (CMT2A) Patient with a Mutation of C.752c>t in MFN2

Generation of a Human Induced Pluripotent Stem Cell Line from a Female Patient Carrying LZTR1 Gene Mutation

Generation of the Human Induced Pluripotent Stem Cell Line (Zjui005-A) from a Patient with Pelizaeus-Merzbacher Disease (PMD) Carrying a Novel Hemizygous Mutation in PLP1 Gene

Identification and characterization of a novel 43-bp deletion mutation of the ATP7B gene in a Chinese patient with Wilson's disease: a case report

Generation of an Induced Pluripotent Stem Cell Line from a Long QT Syndrome Patient Carrying KCNH2/1956C > A Mutation.

Identification of mutations in the ATP7B gene in 14 Wilson disease children: Case series

Genetic studies discover novel coding and non‐coding mutations in patients with Wilson's disease in China

Mutation Analysis of the ATP7B Gene in Seven Chinese Families with Wilson's Disease

Clinical Characteristics and Induced Pluripotent Stem Cells (ipscs) Disease Model of Harel-Yoon Syndrome Caused by Compound Heterozygous ATAD3A Variants

Wilson Disease: Identification of Two Novel Mutations and Clinical Correlation in Eastern Chinese Patients

Identification of potential modifier genes in Chinese patients with Wilson disease

ATP7B gene therapy of autologous reprogrammed hepatocytes alleviates copper accumulation in a mouse model of Wilson’s disease